BIO investing in unique radiopharmaceutical platform company, developing radioligands with prolonged tumour retention ...

Adaptive Computation LLC Assessed “Awardable” for DARPA[JR1] ERIS Marketplace – Adaptive Computation LLC, a leading provider ...

BIO investing in unique radiopharmaceutical platform company, developing radioligands with prolonged tumour retention Series A was co-led by 4BIO Capital, founding investor M Ventures, Hadean Ventures ...

Actithera’s radiopharma assets irreversibly bind to their targets, allowing for longer retention of the drug inside tumors.

Series A co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital with syndicate including Bioqube Ventures, Surveyor Capital and othersLed ...

Glenn Howerton, longtime co-star of hit series “It’s Always Sunny in Philadelphia,” recently revealed why he almost exited ...

Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that, on July 1, 2025, the company ...

For example, the Swiss firm Bottmedical, which is pioneering the use of bio-based materials to replace traditional ...

Armed with the latest biological knowledge and cutting-edge computational techniques—and, of course, investor dollars—these ...

SpyGlass Pharma Inc. has raised a $75 million Series D round that brings the company closer to commercializing its ...

Finally this week, Helsinki, Finland company TILT Biotherapeutics (Tiltbio) raised €22.6 million ($25.6 million) in a Series B that will be used to support the development of a pipeline of ...

Broncos Wire 's 90-man offseason roster series continues today with a look at third-year running back Jaleel McLaughlin, No.